---
figid: PMC11603874__13046_2024_3218_Fig6_HTML
figtitle: TNFA/TNFR2-mediated invasion and metastasis in BC TME
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11603874
filename: 13046_2024_3218_Fig6_HTML.jpg
figlink: /pmc/articles/PMC11603874/figure/F6/
number: F6
caption: TNF-α/TNFR2-mediated invasion and metastasis in BC TME. TNFR2 signals can
  stimulate various proteins and signaling pathways, supporting almost all aspects
  of BC cell invasion and metastasis. For tumor cells to move from the primary tumor
  site by undergoing intravasation first and then extravasation, several enzymes,
  such as MMPs, must degrade the ECM. Many signaling pathways, in addition to several
  cytokines, chemokines, chemokine receptors, and growth factors, control the endothelial
  junctional proteins to induce membrane permeability. These events facilitate the
  movement of tumor cells, proliferation, vascularization, migration, and metastasis
  of BC to generate new tumors at distant sites and organs. c-DC1, type 1 conventional
  DCs; BC, breast cancer; BCSCs, breast cancer stem cells; MDSCs, myeloid-derived
  suppressor cells; T-regs, T regulatory cells; B-regs, B regulatory cells, CAFs,
  cancer associated fibroblast; EPCs, endothelial; MSCs, mesenchymal stem cells; TME,
  tumor microenvironment; ECM, extracellular matrix; MMPs, matrix metalloproteinases;
  iNOS, inducible nitric oxide synthase; NO, nitric oxide; TNF-α, membrane-bound tumor
  necrosis factor; TNFR2, tumor necrosis factor receptor type two; IL-1β, interleukin
  1 beta; IL-6, interleukin 6; IL-8, interleukin 8; HIF-1α, hypoxia inducible factor
  1 alpha; VEGF, vascular endothelial growth factor; pDGF, platelet-derived growth
  factor; IGF, insulin-like growth factor; FGF, fibroblast growth factor; HGF; CSF-1,
  colony stimulating factor 1; TGF-β, transforming-growth factor β; uPA, urokinase-type
  plasminogen; TWIST1, twist related protein-1; CCL-2, chemokine (C–C) motif ligand
  2; CXCR1, C-X-C chemokine receptor 1; CXCR2, C-X-C chemokine receptor 2; CXCR-4,
  C-X-C chemokine receptor 4; CXCR7, C-X-C chemokine receptor 7; CCR2, C–C chemokine
  receptor type 2; CXCL-1, C-X-C motif chemokine ligand 1; CXCL-2, C-X-C motif chemokine
  ligand 2; CXCL-5, C-X-C motif chemokine ligand 5; CXCL-12, C-X-C motif chemokine
  ligand 12
papertitle: Understanding the role of TNFR2 signaling in the tumor microenvironment
  of breast cancer
reftext: Ali Mussa, et al. J Exp Clin Cancer Res. 2024;43(NA).
year: '2024'
doi: 10.1186/s13046-024-03218-1
journal_title: 'Journal of Experimental & Clinical Cancer Research : CR'
journal_nlm_ta: J Exp Clin Cancer Res
publisher_name: BMC
keywords: Immune checkpoint | Immunosuppressive TME | TNF | TNFRSF1B | CD120b
automl_pathway: 0.7333835
figid_alias: PMC11603874__F6
figtype: Figure
redirect_from: /figures/PMC11603874__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11603874__13046_2024_3218_Fig6_HTML.html
  '@type': Dataset
  description: TNF-α/TNFR2-mediated invasion and metastasis in BC TME. TNFR2 signals
    can stimulate various proteins and signaling pathways, supporting almost all aspects
    of BC cell invasion and metastasis. For tumor cells to move from the primary tumor
    site by undergoing intravasation first and then extravasation, several enzymes,
    such as MMPs, must degrade the ECM. Many signaling pathways, in addition to several
    cytokines, chemokines, chemokine receptors, and growth factors, control the endothelial
    junctional proteins to induce membrane permeability. These events facilitate the
    movement of tumor cells, proliferation, vascularization, migration, and metastasis
    of BC to generate new tumors at distant sites and organs. c-DC1, type 1 conventional
    DCs; BC, breast cancer; BCSCs, breast cancer stem cells; MDSCs, myeloid-derived
    suppressor cells; T-regs, T regulatory cells; B-regs, B regulatory cells, CAFs,
    cancer associated fibroblast; EPCs, endothelial; MSCs, mesenchymal stem cells;
    TME, tumor microenvironment; ECM, extracellular matrix; MMPs, matrix metalloproteinases;
    iNOS, inducible nitric oxide synthase; NO, nitric oxide; TNF-α, membrane-bound
    tumor necrosis factor; TNFR2, tumor necrosis factor receptor type two; IL-1β,
    interleukin 1 beta; IL-6, interleukin 6; IL-8, interleukin 8; HIF-1α, hypoxia
    inducible factor 1 alpha; VEGF, vascular endothelial growth factor; pDGF, platelet-derived
    growth factor; IGF, insulin-like growth factor; FGF, fibroblast growth factor;
    HGF; CSF-1, colony stimulating factor 1; TGF-β, transforming-growth factor β;
    uPA, urokinase-type plasminogen; TWIST1, twist related protein-1; CCL-2, chemokine
    (C–C) motif ligand 2; CXCR1, C-X-C chemokine receptor 1; CXCR2, C-X-C chemokine
    receptor 2; CXCR-4, C-X-C chemokine receptor 4; CXCR7, C-X-C chemokine receptor
    7; CCR2, C–C chemokine receptor type 2; CXCL-1, C-X-C motif chemokine ligand 1;
    CXCL-2, C-X-C motif chemokine ligand 2; CXCL-5, C-X-C motif chemokine ligand 5;
    CXCL-12, C-X-C motif chemokine ligand 12
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFRSF1B
  - CD4
  - SNAI2
  - SNAI1
  - TWIST1
  - GEMIN2
  - SCAF11
  - NHERF2
  - ZEB2
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - KRAS
  - HRAS
  - NRAS
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - EGFR
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - STAT3
  - HGF
  - IL6
  - SOS1
  - CSF1
  - IGF1
  - TGFB1
  - TGFB2
  - TGFB3
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - CCL2
  - ITK
  - SLC22A3
  - SELE
  - SELL
  - SELP
  - IL1A
  - IL1B
  - TNF
  - BPIFA4P
  - NOS2
  - ISYNA1
  - MMP2
  - MMP9
  - MMP3
  - PLAU
  - PRAP1
  - CXCR1
  - CXCR2
  - CCR2
  - CXCR4
  - ACKR3
  - CXCL5
---
